Koninklijke Philips EBITDA 2010-2024 | PHG

Koninklijke Philips annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Koninklijke Philips EBITDA for the quarter ending September 30, 2024 was $0.879B, a 758.01% increase year-over-year.
  • Koninklijke Philips EBITDA for the twelve months ending September 30, 2024 was $0.507B, a 54.03% decline year-over-year.
  • Koninklijke Philips 2023 annual EBITDA was $1.249B, a 17.16% decline from 2022.
  • Koninklijke Philips 2022 annual EBITDA was $1.508B, a 32.61% decline from 2021.
  • Koninklijke Philips 2021 annual EBITDA was $2.237B, a 38.91% decline from 2020.
Koninklijke Philips Annual EBITDA
(Millions of US $)
2023 $1,249
2022 $1,508
2021 $2,237
2020 $3,662
2019 $3,521
2018 $3,316
2017 $2,890
2016 $3,517
2015 $2,577
2014 $2,252
2013 $4,487
2012 $3,186
2011 $3,471
2010 $4,530
2009 $2,823
Koninklijke Philips Quarterly EBITDA
(Millions of US $)
2024-06-30 $879
2023-06-30 $242
2023-03-31 $-626
2022-06-30 $12
2021-06-30 $102
2020-06-30 $252
2019-06-30 $392
2018-06-30 $355
2017-06-30 $278
2016-12-31 $1,287
2016-09-30 $867
2016-06-30 $776
2016-03-31 $587
2015-12-31 $618
2015-09-30 $733
2015-06-30 $750
2015-03-31 $476
2014-12-31 $368
2014-09-30 $275
2014-06-30 $870
2014-03-31 $739
2013-12-31 $1,544
2013-09-30 $1,067
2013-06-30 $1,069
2013-03-31 $807
2012-12-31 $652
2012-09-30 $1,166
2012-06-30 $638
2012-03-31 $1,037
2011-12-31 $601
2011-09-30 $623
2011-06-30 $864
2011-03-31 $1,267
2010-12-31 $1,532
2010-09-30 $1,099
2010-06-30 $924
2010-03-31 $994
2009-12-31 $2,828
2009-09-30 $1,047
2009-06-30 $-658
2009-03-31 $181
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $25.642B $19.663B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $221.767B 27.38
Boston Scientific (BSX) United States $151.377B 43.52
Stryker (SYK) United States $149.082B 32.08
EssilorLuxottica (ESLOY) France $125.055B 0.00
Medtronic (MDT) Ireland $117.214B 17.41
Lonza Group Ag (LZAGY) Switzerland $45.950B 0.00
Haleon (HLN) United Kingdom $43.139B 28.03
GE HealthCare Technologies (GEHC) United States $40.136B 20.82
ResMed (RMD) United States $37.119B 30.50
Terumo (TRUMY) Japan $28.886B 41.07
Zimmer Biomet Holdings (ZBH) United States $22.107B 14.07
Insulet (PODD) United States $19.438B 77.40
Baxter (BAX) United States $16.737B 10.89
Smith & Nephew SNATS (SNN) United Kingdom $11.065B 0.00
BellRing Brands (BRBR) United States $10.084B 40.57
Sunny Optical Technology (SNPTF) China $9.976B 0.00
Bio-Rad Laboratories (BIO) United States $9.966B 33.87
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.433B 14.95
ICU Medical (ICUI) United States $4.121B 39.23
Prestige Consumer Healthcare (PBH) United States $3.893B 19.36
Envista Holdings (NVST) United States $3.678B 27.40
Haemonetics (HAE) United States $3.430B 16.74
Perrigo (PRGO) Ireland $3.366B 9.91
GN Store Nord (GNNDY) Denmark $3.027B 19.41
Shandong Weigao Medical Polymer (SHWGF) China $2.989B 0.00
QuidelOrtho (QDEL) United States $2.927B 18.84
Neogen (NEOG) United States $2.495B 28.75
LeMaitre Vascular (LMAT) United States $2.247B 54.60
AtriCure (ATRC) United States $2.067B 0.00
Green Thumb Industries (GTBIF) United States $1.464B 25.63
InMode (INMD) Israel $1.462B 8.79
AdaptHealth (AHCO) United States $1.430B 10.22
BioLife Solutions (BLFS) United States $1.313B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.270B 0.00
Owens & Minor (OMI) United States $1.150B 8.99
Evolus (EOLS) United States $0.922B 0.00
Phibro Animal Health (PAHC) United States $0.887B 15.64
CeriBell (CBLL) United States $0.833B 0.00
Curaleaf Holdings (CURLF) Canada $0.830B 0.00
Capricor Therapeutics (CAPR) United States $0.649B 0.00
VAREX IMAGING (VREX) United States $0.561B 24.73
Surmodics (SRDX) United States $0.511B 0.00
Omeros (OMER) United States $0.502B 0.00
Cresco Labs (CRLBF) United States $0.432B 0.00
Verano Holdings (VRNOF) United States $0.429B 0.00
Valneva SE (VALN) France $0.412B 0.00
ZimVie (ZIMV) United States $0.401B 33.77
Quanterix (QTRX) United States $0.370B 0.00
Cerus (CERS) United States $0.360B 0.00
Viemed Healthcare (VMD) United States $0.322B 30.67
Sanara MedTech (SMTI) United States $0.317B 0.00
Biote (BTMD) United States $0.309B 6.76
OraSure Technologies (OSUR) United States $0.291B 19.50
Canopy Growth (CGC) Canada $0.265B 0.00
Zynex (ZYXI) United States $0.263B 55.13
High Tide (HITI) Canada $0.239B 0.00
Sanuwave Health (SNWV) United States $0.233B 3.28
Utah Medical Products (UTMD) United States $0.208B 15.52
Aurora Cannabis (ACB) Canada $0.203B 0.00
Brainsway (BWAY) Israel $0.197B 104.70
MacroGenics (MGNX) United States $0.190B 0.00
Organigram Holdings (OGI) Canada $0.189B 0.00
TerrAscend (TSNDF) Canada $0.154B 0.00
TriSalus Life Sciences (TLSI) United States $0.149B 0.00
FitLife Brands (FTLF) United States $0.145B 18.27
Quipt Home Medical (QIPT) United States $0.135B 0.00
Jin Medical (ZJYL) China $0.125B 0.00
Fonar (FONR) United States $0.102B 11.54
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Veru (VERU) United States $0.089B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.072B 0.00
INLIF (INLF) $0.071B 0.00
Rockwell Medical (RMTI) United States $0.066B 34.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
Apyx Medical (APYX) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.055B 0.00
Modular Medical (MODD) United States $0.051B 0.00
Ayr Wellness (AYRWF) United States $0.051B 0.00
United-Guardian (UG) United States $0.050B 14.35
ImmuCell (ICCC) United States $0.048B 0.00
Safety Shot (SHOT) United States $0.031B 0.00
Nephros (NEPH) United States $0.018B 0.00
Allurion Technologies (ALUR) United States $0.015B 0.00
Innovative Eyewear (LUCY) United States $0.013B 0.00
Flora Growth (FLGC) United States $0.011B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.009B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.002B 0.00
Sharps Technology (STSS) United States $0.001B 0.00
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00